Recurrent Adult Acute Lymphoblastic Leukemia

specific

The reemergence of acute lymphoblastic leukemia in adults after a period of remission.

67

Centers

31

Active Trials

Cancer Funding

Top Centers for Recurrent Adult Acute Lymphoblastic Leukemia(67)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
62.8
2
NCI Comprehensive
Active Research Program
62.8
3
NCI Comprehensive
Active Research Program
62.8
4
NCI Comprehensive
Active Research Program
62.8
5
NCI Comprehensive
Active Research Program
62.8
6
NCI Comprehensive
Active Research Program
62.8
7
NCI Comprehensive
Active Research Program
62.8
8
NCI Comprehensive
Active Research Program
62.8
9
NCI Comprehensive
Active Research Program
62.8
10
NCI Comprehensive
Active Research Program
62.8
11
NCI Comprehensive
Active Research Program
62.8
1262.8
13
NCI Comprehensive
Active Research Program
62.8
14
NCI Comprehensive
Active Research Program
62.8
15
NCI Comprehensive
Active Research Program
62.8
16
NCI Clinical
Active Research Program
62.8
17
NCI Comprehensive
Active Research Program
62.8
18
NCI Comprehensive
Active Research Program
62.8
19
NCI Clinical
Active Research Program
62.8
20
NCI Comprehensive
Active Research Program
62.8
21
Active Research Program
62.8
22
Active Research Program
62.8
23
NCI Comprehensive
Active Research Program
62.8
24
Active Research Program
62.8
25
NCI Comprehensive
Active Research Program
62.8
26
Active Research Program
62.8
27
Active Research Program
62.8
28
Active Research Program
62.8
29
Active Research Program
62.8
30
Active Research Program
62.8
31
Active Research Program
62.8
32
NCI Comprehensive
40.3
33
NCI Comprehensive
40.3
34
NCI Comprehensive
40.3
35
NCI Comprehensive
40.3
36
NCI Comprehensive
40.3
37
NCI Comprehensive
40.3
3840.3
3940.3
40
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
40.3
41
NCI Comprehensive
40.3
42
NCI Comprehensive
40.3
43
NCI Comprehensive
40.3
44
NCI Comprehensive
40.3
45
NCI Comprehensive
40.3
46
Cedars-Sinai CancerLos Angeles, CA
40.3
4740.3
48
NCI Comprehensive
40.3
4940.3
5040.3
5140.3
52
NCI Comprehensive
40.3
53
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
40.3
5440.3
5540.3
5640.3
57
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
40.3
5840.3
5940.3
6040.3
6140.3
6240.3
6340.3
6440.3
6540.3
66
BC CancerVancouver, BC
40.3
6740.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →